IDH1-IN-1

CAS No. 1355326-21-4

IDH1-IN-1 ( Mutant IDH1-IN-1 )

Catalog No. M11452 CAS No. 1355326-21-4

Mutant IDH1-IN-1 is a potent mutant IDH1 R132H inhibitor with IC50 < 0.1 uM(A level in Patent).

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 84 In Stock
5MG 140 In Stock
10MG 215 In Stock
25MG 412 In Stock
50MG 606 In Stock
100MG 862 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    IDH1-IN-1
  • Note
    Research use only, not for human use.
  • Brief Description
    Mutant IDH1-IN-1 is a potent mutant IDH1 R132H inhibitor with IC50 < 0.1 uM(A level in Patent).
  • Description
    Mutant IDH1-IN-1 is a potent mutant IDH1 R132H inhibitor with IC50 < 0.1 uM(A level in Patent); more bioactivity information in Patent WO2012009678A1(Example 135).
  • Synonyms
    Mutant IDH1-IN-1
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Dehydrogenase
  • Recptor
    mutant IDH1 R132H
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    1355326-21-4
  • Formula Weight
    498.59
  • Molecular Formula
    C30H31FN4O2
  • Purity
    >98%(HPLC)
  • Solubility
    DMSO: 10 mM
  • SMILES
    O=C(NC1CCCCC1)C(N(C(CN2C3=CC=CC=C3N=C2)=O)C4=CC=CC(F)=C4)C5=CC=CC=C5C
  • Chemical Name
    2-(N-[2-(Benzimidazol-1-yl)acetyl]-3-fluoroanilino)-N-cyclohexyl-2-(2-methylphenyl)acetamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Janeta Popovici-Muller, et al. Patent WO2012009678 A
molnova catalog
related products
  • Atovaquone

    Atovaquone is a medication used to treat or prevent for pneumocystis pneumonia, toxoplasmosis, malaria, and babesia.

  • DHODH-IN-15

    DHODH-IN-15 is the hydroxyfuran analogue of A771726.

  • Taraxerone

    Taraxerone has allelopathic and antifungal effects.Taraxerone prevents catalase, superoxide dismutase, and reduces glutathione concentrations from the decrease induced by ethanol administration with the concentration dependent manner.